Literature DB >> 15289936

The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa.

M-H Ruchaud-Sparagano1, B R Westley, F E B May.   

Abstract

The trefoil protein TFF1 is expressed principally in the superficial cells of the gastric mucosa. It is a small protein and forms homo- and hetero-dimers via a disulphide bond through Cys58 which is located three amino acids from the C terminus. TFF1 is co-expressed with the secreted mucin MUC5AC in superficial cells of the gastric mucosa suggesting that it could be involved in the packaging or function of gastric mucus. We have previously shown that TFF1 co-sediments with mucin glycoproteins on caesium chloride gradients. To extend this observation we have now used gel filtration under physiological conditions, immunoprecipitation and Western transfer analysis to characterise the interaction of TFF1 with gastric mucin glycoproteins. We show that TFF1 co-elutes with MUC5AC but not MUC6 on gel filtration and that immunoprecipitation and Western transfer analysis confirms that TFF1 interacts with MUC5AC. We also demonstrate that the TFF1 dimer is the predominant molecular form bound to MUC5AC. Salt and chelators of divalent cations such as EDTA and EGTA disrupted the TFF1- MUC5AC interaction and increased the degradation of MUC5AC, whereas calcium increased the amount of TFF1 bound to MUC5AC. These data support the contention that TFF1 is pivotal in the packaging and function of human gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289936     DOI: 10.1007/s00018-004-4124-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  46 in total

1.  Thrombolysis in Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Bivalirudin started during emergency transport for primary PCI.

Authors:  Philippe Gabriel Steg; Arnoud van 't Hof; Christian W Hamm; Peter Clemmensen; Frédéric Lapostolle; Pierre Coste; Jurrien Ten Berg; Pierre Van Grunsven; Gerrit Jan Eggink; Lutz Nibbe; Uwe Zeymer; Marco Campo dell' Orto; Holger Nef; Jacob Steinmetz; Louis Soulat; Kurt Huber; Efthymios N Deliargyris; Debra Bernstein; Diana Schuette; Jayne Prats; Tim Clayton; Stuart Pocock; Martial Hamon; Patrick Goldstein
Journal:  N Engl J Med       Date:  2013-10-30       Impact factor: 91.245

3.  Diagnosis of cardiogenic shock without the use of a pulmonary artery catheter.

Authors:  Howard A Cooper; Amir H Najafi; Kambiz Ghafourian; Andre Rm Paixao; Mohamed Aljaabari; Micaela Iantorno; Daniel Caños; Federico M Asch; Julio A Panza
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2014-05-15

4.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

5.  Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.

Authors:  Holger Thiele; Peter Sick; Enno Boudriot; Klaus-Werner Diederich; Rainer Hambrecht; Josef Niebauer; Gerhard Schuler
Journal:  Eur Heart J       Date:  2005-02-25       Impact factor: 29.983

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.

Authors:  Raban V Jeger; Philip Urban; Shannon M Harkness; Chi-Hong Tseng; Jean-Christophe Stauffer; Thierry H Lejemtel; Lynn A Sleeper; Matthias E Pfisterer; Judith S Hochman
Journal:  Acute Card Care       Date:  2011-01-18

Review 8.  Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Authors:  Jin M Cheng; Corstiaan A den Uil; Sanne E Hoeks; Martin van der Ent; Lucia S D Jewbali; Ron T van Domburg; Patrick W Serruys
Journal:  Eur Heart J       Date:  2009-07-18       Impact factor: 29.983

9.  Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.

Authors:  Sean van Diepen; Harmony R Reynolds; Amanda Stebbins; Renato D Lopes; Vladimír Džavík; Witold Ruzyllo; Alexander Geppert; Petr Widimsky; E Magnus Ohman; Joseph E Parrillo; Harold L Dauerman; David A Baran; Judith S Hochman; John H Alexander
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

10.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  28 in total

1.  Altered expression of CDX-2, PDX-1 and mucin core proteins in "Ulcer-associated cell lineage (UACL)" in Crohn's disease.

Authors:  Yasunori Kaneko; Takamichi Nakamura; Masayoshi Hayama; Noriko Hosaka; Taiji Akamatsu; Hiroyoshi Ota
Journal:  J Mol Histol       Date:  2007-10-24       Impact factor: 2.611

2.  Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.

Authors:  Jin Dai; Ning Zhang; Jinhui Wang; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2014-01-10

3.  Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa.

Authors:  H Ota; M Hayama; M Momose; Hala M T El-Zimaity; K Matsuda; K Sano; F Maruta; N Okumura; T Katsuyama
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

4.  Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice.

Authors:  Seiko Kubota; Kazuyoshi Yamauchi; Mitsutoshi Sugano; Kenji Kawasaki; Atsushi Sugiyama; Kenji Matsuzawa; Taiji Akamatsu; Yasukazu Ohmoto; Hiroyoshi Ota
Journal:  Dig Dis Sci       Date:  2011-05-11       Impact factor: 3.199

Review 5.  Trefoil Factor Peptides and Gastrointestinal Function.

Authors:  Eitaro Aihara; Kristen A Engevik; Marshall H Montrose
Journal:  Annu Rev Physiol       Date:  2016-12-15       Impact factor: 19.318

Review 6.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

7.  Virulent Shigella flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells.

Authors:  Brice Sperandio; Natalie Fischer; Marie Joncquel Chevalier-Curt; Yannick Rossez; Pascal Roux; Catherine Robbe Masselot; Philippe J Sansonetti
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

8.  Hyperplastic polyps and sessile serrated 'adenomas' of the colon and rectum display gastric pyloric differentiation.

Authors:  Akiyoshi Mochizuka; Takeshi Uehara; Takamichi Nakamura; Yukihiro Kobayashi; Hiroyoshi Ota
Journal:  Histochem Cell Biol       Date:  2007-09-12       Impact factor: 4.304

9.  In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.

Authors:  Ling C Huang; Rachel L Redfern; Srihari Narayanan; Rose Y Reins; Alison M McDermott
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

10.  Gastric mucus alterations associated with murine Helicobacter infection.

Authors:  Julia M Schmitz; Carolyn G Durham; Samuel B Ho; Robin G Lorenz
Journal:  J Histochem Cytochem       Date:  2009-01-19       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.